Table 3.
Comparison of Complement Levels in Age Subgroups of Male AMD Patients and Controls
AMD | Control | t value | P value | |
---|---|---|---|---|
Male | ||||
Age≤56 | ||||
C1q(mg/dL) | 206.85±22.40 | 173.52±50.85 | 2.074 | 0.056a |
C3(mg/dL) | 121.02±16.51 | 119.93±19.85 | 0.158 | 0.875a |
C4(mg/dL) | 29.01±6.46 | 33.10±39.03 | −0.342 | 0.734a |
56<age≤65 | ||||
C1q(mg/dL) | 176.01±34.39 | 172.35±35.36 | 0.309 | 0.759a |
C3(mg/dL) | 120.05±15.62 | 114.13±17.49 | 1.045 | 0.304a |
C4(mg/dL) | 25.61±8.18 | 26.28±7.81 | −0.247 | 0.806a |
65<age≤71 | ||||
C1q(mg/dL) | 201.21±42.47 | 214.05±16.90 | −0.413 | 0.685a |
C3(mg/dL) | 112.91±13.88 | 133.56±11.27 | −2.046 | 0.059a |
C4(mg/dL) | 29.07±8.51 | 26.69±25.07 | 0.302 | 0.767a |
Age>71 | ||||
C1q(mg/dL) | 195.46±33.86 | 220.03±44.93 | −1.742 | 0.092a |
C3(mg/dL) | 121.38±18.67 | 120.23±25.80 | 0.145 | 0.886a |
C4(mg/dL) | 26.21±6.37 | 31.59±7.89 | −1.955 | 0.067a |
Note: aIndependent samples t-test.